Risperidone Long-Acting Injection Suppliers & Bulk Manufacturers
Available Forms: Long-Acting Injection
Available Strengths: 12.5 mg, 25 mg, 37.5 mg, 50 mg vials/syringes
Reference Brands: Risperdal Consta(US &EU)
Category: Antipsychotropic Drugs
Risperidone long-acting injection (12.5 to 50 mg) is given into a muscle every two weeks for schizophrenia and bipolar disorder, using risperidone in slow-release microspheres. Oral risperidone is needed for the first three weeks. It needs cold-chain storage at 2–8 °C. The original product is Risperdal Consta. Ask PharmaTradz for a quote; we confirm the manufacturer, registration documents and lead time for your country.
Manufacture or export Risperidone Long-Acting Injection? List it or send an offer →
Product Description:
Risperidone Long-Acting Injection, commonly marketed as Risperdal Consta, is a second-generation antipsychotic approved in both the US (FDA) and EU (EMA) for the treatment of schizophrenia and maintenance therapy in bipolar disorder. It is administered intramuscularly every two weeks and provides steady plasma levels, improving adherence in patients with chronic psychosis. The drug requires prior oral risperidone trial before initiating long-acting therapy. In the EU, it is approved under centralized and national procedures. In the US, it holds FDA approval under NDA. Its prolonged-release formulation is protected by a series of patents, though generic development has begun in select markets.
Risperidone Long-Acting Injection — third party manufacturing & bulk supply
Risperidone Long-Acting Injection is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:
Indicative minimum order quantity
Risperidone Long-Acting Injection is supplied as Long-Acting Injection — an injectable dosage form, so the indicative MOQ is 50,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.
Manufacturers of Risperidone Long-Acting Injection listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.
Request a quote for Risperidone Long-Acting Injection →Usually answered within 48 hours, with matched manufacturers, indicative prices and document status.
Frequently Asked Questions
Risperidone injection is used for the treatment of schizophrenia and sometimes bipolar disorder. Long-acting formulations are given to patients who need consistent antipsychotic treatment and may have difficulty taking daily oral medication. It helps control symptoms such as hallucinations, delusions, mood changes, and disorganized thinking.
Risperidone injection is made from the active pharmaceutical ingredient risperidone, an atypical antipsychotic compound that works by affecting dopamine and serotonin receptors in the brain. Long-acting injectable versions use specialized delivery systems that release the medicine slowly over time.
The main trade names include Risperdal Consta, Perseris, Uzedy, and Rykindo, along with several regional brand names depending on the country and manufacturer.
Risperdal Consta is manufactured by Janssen Pharmaceuticals (a Johnson & Johnson company). Perseris is produced by Indivior. Uzedy is developed by Teva Pharmaceuticals in collaboration with Medincell. Rykindo is produced by Luye Pharma Group. In India and other markets, various pharmaceutical manufacturers produce risperidone long-acting injections under licensed or local brands.
The generic name is risperidone.
Major brand names include Risperdal Consta, Perseris, Uzedy, and Rykindo.
Risperidone injections are manufactured in multiple countries depending on the brand, including the United States, European Union countries, China, and India, under approved pharmaceutical manufacturing facilities that comply with regulatory standards such as US FDA, EMA, and other national authorities.
The microsphere powder is mixed with its diluent just before injection, using the supplied kit, and injected into the deltoid or gluteal muscle every 2 weeks.
The microspheres release little drug for about 3 weeks, so oral risperidone covers the first 3 weeks.
At 2–8 °C; it can be kept at room temperature for up to 7 days before use.
Related Products
Zuclopenthixol Long-Acting Im Injection (Depot)
Strength:
200 mg/mL, 500 mg/mL
Form: Long-acting IM Injection (Depot)
Reference Brands: Clopixol Depot (EU)
View DetailsZuclopenthixol Short-Acting Intramuscular Injection
Strength:
50 mg/mL
Form: Short-acting Intramuscular Injection
Reference Brands: Clopixol-Acuphase®
View DetailsZuclopenthixol Tablets
Strength:
10 mg, 25 mg, 40 mg
Form: Oral Tablets
Reference Brands: Clopixol®(EU)
View DetailsPimozide Tablets
Strength:
1 mg, 2 mg, 4 mg
Form: Oral Tablets
Reference Brands: Orap®(US & EU)
View DetailsNalmefene Hydrochloride Injectable Solution
Strength:
1 mg/mL in 1 mL or 2 mL vials
Form: Injectable Solution
Reference Brands: Selincro(EU)
View DetailsTemazepam Oral Capsules
Strength:
7.5 mg, 15 mg, 22.5 mg, 30 mg
Form: Oral Capsules
Reference Brands: Restoril (US)
View DetailsDiazepam Oral Tablets
Strength:
2 mg, 5 mg, 10 mg
Form: Oral Tablets
Reference Brands: Valium®(EU & US)
View DetailsDiazepam Oral Solution
Strength:
2.5 mg/mL, 5 mg/mL
Form: Oral Solution
Reference Brands: Valium®(EU & US)
View DetailsUsually answered within 48 hours | GMP documents shared before you commit